Surging Prevalence Of Cardiovascular Disorders Driving Growth In The Structural Heart Market: Core Growth Enabler in the Structural Heart Market, 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Structural Heart Industry Market Size Be by 2025?
The size of the structural heart market has significantly expanded in the past few years. It is projected to escalate from $14.9 billion in 2024 to $15.99 billion in 2025, showcasing a compound annual growth rate (CAGR) of 7.3%. The growth during the historic era can be credited to improved awareness and screening, robustness within the supply chain, boosted healthcare expenditure, market consolidation, and heightened understanding of cardiovascular diseases.

What's the Long-Term Growth Forecast for the Structural Heart Market Size Through 2029?
In the forthcoming years, the structural heart market is predicted to experience robust growth, expanding to a market size of $22.43 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 8.8%. Factors contributing to this increased growth during the forecasted period include a heightened need for heart valve devices, an ageing demographic, increased occurrence of cardiovascular diseases, as well as market segmentation and regional market growth. Foreseen trends within this duration encompass new product introductions, advancements in technology, economic recuperation, regulatory enactments, an escalating rate of cardiovascular diseases and innovative developments in medical devices.

View the full report here:
https://www.thebusinessresearchcompany.com/report/structural-heart-global-market-report

What Are the Key Growth Drivers Fueling the Structural Heart Market Expansion?
The escalation in cardiovascular ailments anticipates bolstering the expansion of the structural heart market. These diseases that impact the heart and blood vessels incorporate conditions like coronary artery disease, heart failure, and stroke. The mounting frequency of these cardiovascular disorders is primarily attributed to the elderly populace, alterations in lifestyle and nutrition, and elevated incidences of obesity and diabetes. Devices and services in the structural heart domain provide evaluation and remedy for structural heart abnormalities disrupting the valves, chambers, and adjacent tissues via minimally invasive measures rather than open-heart surgeries for optimal management with fewer complications risks. For example, a study issued by the American College of Cardiology, a non-profit medical association based in the US, projected that all four cardiovascular risk factors would rise between 2025 and 2060 in the United States, in August 2022. The highest relative surge is foreseen in diabetes, growing by 39.3% to 55 million individuals, succeeded by dyslipidemia (increasing by 27.6% to 126 million), hypertension (rising by 25.1% to 162 million), and obesity (enhancing by 18.3% to 126 million). The study further projected the steepest expected increases in cardiovascular disease rates were for stroke (33.8% to 15 million) and heart failure (33.4% to 13 million), followed by ischemic heart disease (30.7% to 29 million) and heart attack (16.9% to 16 million). Consequently, the proliferating occurrence of cardiovascular disorders is stimulating the expansion of the structural heart market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12029&type=smp

What Are the Key Trends Driving Structural Heart Market Growth?
The rise of technological progress has become a significant trend, gaining traction in the structural heart market. Leading players in the structural heart sector are focusing their endeavors on the development of innovative products to reinforce their market stance. For instance, Eko Health, a digital health establishment based in the US, introduced the SENSORA cardiac disease detection platform for non-invasive heart disease identification to primary care in February 2023. SENSORA utilizes artificial intelligence to effectively determine structural murmurs, an indicator of valvular heart disease, and care pathway analytics software that offers a view into and metrics of the patient's journey throughout the healthcare system by recording and examining heart sounds and electrical signals with its digital stethoscopes. This is meant to assist in crucial decision-making by identifying care gaps that can be converted into improved operational efficiency, such as minimizing delays in care provision, duration of stay, and re-hospitalization rates, while also boosting patient and doctor satisfaction.

How Is the Structural Heart Market Segmented?
The structural heart market covered in this report is segmented -

1) By Product: Occluders, Annuloplasty Rings, Heart Valve Balloons, Other Products
2) By Procedure: Heart Valve Stenosis, Heart Valve Regurgitation, Left Atrial Appendage Closure
3) By End Users: Hospitals, Ambulatory Surgical Centers, Cardiac Centers

Subsegments:
1) By Occluders: Atrial Septal Defect (ASD) Occluders, Patent Foramen Ovale (PFO) Occluders, Ventricular Septal Defect (VSD) Occluders
2) By Annuloplasty Rings: Rigid Annuloplasty Rings, Flexible Annuloplasty Rings, Adjustable Annuloplasty Rings
3) By Heart Valve Balloons: Balloon Expandable Heart Valve Systems, Valvuloplasty Balloons
4) By Other Products: Transcatheter Heart Valves, Structural Heart Imaging Devices, Delivery Systems For Structural Heart Procedures

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12029&type=smp

Which Companies Are Leading the Charge in Structural Heart Market Innovation?
Major companies operating in the structural heart market include Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Edwards Lifesciences Corporation, Trane Technologies, Lepu Medical Technology Co. Ltd., LivaNova PLC, Biomerics LLC, Venus Medtech (Hangzhou) Inc., Cryolife Inc., Endologix Inc., Shockwave Medica Inc., Braile Biomédica, JenaValve Technology Inc., Corvia Medical Inc, HLT Medical, On-X Life Technologies Inc., Symetis SA, Magenta Therapeutics, PASCAL Medical, Micro Interventional Devices Inc., CardioKinetix Inc, Tendyne Holdings Inc., Q'Apel Medical Inc., Neovasc Inc., NVT AG, Z-Medical GmbH + Co. KG

Which Regions Are Leading the Global Structural Heart Market in Revenue?
North America was the largest region in the structural heart market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the structural heart market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12029

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.